Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.15 trillion and total revenue of $111.27 billion.
Market Cap
1.15T
Revenue
111.27B
Profits
-41.69B
PE Ratio
n/a
Profit Margin
-37.47%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.32B | -0.58% | 1,088,229 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 72.53B | -0.97% | 751,858 | 14.92B |
| 3 | ARGX | argenx SE | 50.39B | 2.42% | 197,215 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.18B | 0.68% | 889,662 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 33.87B | -3.77% | 261,905 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.78B | -0.31% | 1,804,796 | - |
| 7 | RPRX | Royalty Pharma plc | 30.75B | 0.28% | 3,513,436 | 2.44B |
| 8 | INSM | Insmed Incorporated | 25.06B | -2.01% | 2,761,442 | 819.56M |
| 9 | BNTX | BioNTech SE | 23.26B | -0.26% | 646,501 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 21.11B | 0.96% | 2,914,285 | 13.31M |
| 11 | MRNA | Moderna, Inc. | 19.85B | -0.77% | 7,668,123 | 2.23B |
| 12 | INCY | Incyte Corporation | 19.50B | -1.20% | 1,350,202 | 5.36B |
| 13 | GMAB | Genmab A/S | 16.20B | 1.32% | 1,519,832 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 15.25B | 0.78% | 278,119 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.50B | -0.55% | 695,886 | 4.44B |
| 16 | SMMT | Summit Therapeutics Inc. | 14.08B | -3.46% | 1,971,829 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.64B | 1.53% | 2,236,877 | 579.96M |
| 18 | EXEL | Exelixis, Inc. | 12.84B | -0.37% | 2,420,733 | 2.38B |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.51B | -2.47% | 1,718,500 | 1.06B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.45B | 4.05% | 343,568 | 1.13B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.95B | -1.30% | 572,430 | 708.24M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.22B | 2.32% | 1,799,276 | 622.01M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.29B | -0.58% | 1,158,855 | 3.24B |
| 24 | CYTK | Cytokinetics, Incorporated | 9.79B | 1.84% | 2,349,096 | 105.82M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 9.63B | -0.38% | 249,383 | 7.46M |
| 26 | ABVX | ABIVAX Société Anonyme | 9.57B | -0.75% | 692,134 | 5.37M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.32B | 1.19% | 375,689 | 417.30M |
| 28 | IBRX | ImmunityBio, Inc. | 8.54B | - | 9,402,569 | 140.98M |
| 29 | NUVL | Nuvalent, Inc. | 8.25B | -0.77% | 303,776 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.21B | -1.17% | 1,454,846 | 1.51B |
| 31 | PCVX | Vaxcyte, Inc. | 7.73B | -1.35% | 1,363,664 | - |
| 32 | TECH | Bio-Techne Corporation | 7.00B | -0.33% | 3,425,767 | 1.21B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.95B | -1.27% | 327,465 | 51.48M |
| 34 | MIRM | Mirum Pharmaceuticals, Inc. | 6.79B | 2.04% | 1,032,370 | 569.61M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.79B | 1.61% | 413,740 | 74.06M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 6.57B | -0.86% | 449,788 | - |
| 37 | CELC | Celcuity Inc. | 6.51B | 8.23% | 2,425,864 | - |
| 38 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.42B | -0.10% | 754,351 | 217.17M |
| 39 | APGE | Apogee Therapeutics, Inc. | 6.29B | -0.04% | 606,992 | - |
| 40 | CORT | Corcept Therapeutics Incorporated | 6.26B | 2.14% | 1,879,054 | 769.10M |
| 41 | SRRK | Scholar Rock Holding Corporation | 6.14B | 2.21% | 2,205,841 | - |
| 42 | CGON | CG Oncology, Inc. | 6.13B | -6.03% | 1,250,503 | 5.07M |
| 43 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.05% | 1,621,898 | 15.00M |
| 44 | PTCT | PTC Therapeutics, Inc. | 6.03B | -1.01% | 591,006 | 827.11M |
| 45 | BLTE | Belite Bio, Inc | 5.90B | -2.33% | 164,570 | - |
| 46 | IMVT | Immunovant, Inc. | 5.89B | -0.99% | 1,218,854 | - |
| 47 | COGT | Cogent Biosciences, Inc. | 5.84B | -0.29% | 1,246,377 | - |
| 48 | TGTX | TG Therapeutics, Inc. | 5.78B | -4.36% | 1,542,228 | 700.35M |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.41B | 0.21% | 1,367,058 | 7.50M |
| 50 | LEGN | Legend Biotech Corporation | 5.29B | -0.24% | 2,223,728 | 1.14B |
| 51 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | -0.07% | - | 1.11B |
| 52 | CRSP | CRISPR Therapeutics AG | 4.87B | -4.36% | 1,664,202 | 4.10M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.67B | -0.47% | 241,399 | 1.34M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.39B | -1.01% | 136,793 | 274.48M |
| 55 | MANE | Veradermics, Incorporated | 4.37B | -1.00% | 347,634 | - |
| 56 | CAI | Caris Life Sciences, Inc. | 4.31B | 3.81% | 3,809,872 | 907.29M |
| 57 | NAMS | NewAmsterdam Pharma Company N.V. | 4.24B | -2.30% | 1,297,912 | 22.57M |
| 58 | TVTX | Travere Therapeutics, Inc. | 4.10B | -1.01% | 3,051,899 | 536.20M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.04B | 2.21% | 1,285,198 | 18.07M |
| 60 | ORKA | Oruka Therapeutics, Inc. | 3.85B | 1.14% | 1,084,411 | - |
| 61 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | - | 4,128,578 | 596.96M |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.78B | -0.41% | 2,029,032 | 1.10B |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.68B | 0.03% | 1,434,152 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.66B | 0.74% | 837,259 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.64B | 3.23% | 106,336 | 803.79M |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.60B | -2.51% | 5,401,768 | 56.99M |
| 67 | ERAS | Erasca, Inc. | 3.22B | -0.86% | 3,298,745 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.14B | -0.20% | 695,220 | 236.00M |
| 69 | ALMS | Alumis Inc. | 3.13B | -0.93% | 507,020 | 8.40M |
| 70 | DNLI | Denali Therapeutics Inc. | 3.08B | -2.07% | 1,828,143 | - |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.02B | -0.87% | 913,112 | - |
| 72 | BEAM | Beam Therapeutics Inc. | 2.94B | -7.28% | 2,424,202 | 164.01M |
| 73 | VERA | Vera Therapeutics, Inc. | 2.84B | 1.05% | 1,016,944 | - |
| 74 | GPCR | Structure Therapeutics Inc. | 2.83B | 4.62% | 825,642 | - |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 2.80B | 0.80% | 603,920 | 535.08M |
| 76 | KLRA | Kailera Therapeutics, Inc. | 2.79B | 1.85% | 340,389 | - |
| 77 | SLNO | Soleno Therapeutics, Inc. | 2.76B | 0.08% | 1,393,710 | 285.01M |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 2.70B | -0.55% | 1,865,777 | 415.62M |
| 79 | IRON | Disc Medicine, Inc. | 2.66B | -0.47% | 560,845 | - |
| 80 | ELVN | Enliven Therapeutics, Inc. | 2.62B | -1.10% | 562,597 | - |
| 81 | NBTX | Nanobiotix S.A. | 2.61B | 5.82% | 142,426 | 38.27M |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.55B | -0.18% | 576,699 | 865.00K |
| 83 | IDYA | IDEAYA Biosciences, Inc. | 2.53B | -0.21% | 749,965 | 225.27M |
| 84 | RARE | Ultragenyx Pharmaceutical Inc. | 2.53B | -2.49% | 1,161,356 | 670.00M |
| 85 | NKTR | Nektar Therapeutics | 2.51B | -2.13% | 788,732 | 55.63M |
| 86 | IMNM | Immunome, Inc. | 2.49B | -0.81% | 603,759 | 4.02M |
| 87 | RLAY | Relay Therapeutics, Inc. | 2.45B | -3.33% | 4,381,440 | 10.68M |
| 88 | KOD | Kodiak Sciences Inc. | 2.42B | -2.30% | 474,241 | - |
| 89 | DFTX | Definium Therapeutics, Inc. | 2.33B | -3.00% | 1,087,076 | - |
| 90 | ZLAB | Zai Lab Limited | 2.28B | -0.68% | 1,054,779 | 453.28M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.25B | 1.53% | 708,515 | - |
| 92 | TYRA | Tyra Biosciences, Inc. | 2.17B | 0.88% | 534,456 | - |
| 93 | TRVI | Trevi Therapeutics, Inc. | 2.14B | -1.24% | 1,311,797 | - |
| 94 | OCUL | Ocular Therapeutix, Inc. | 2.08B | 2.81% | 2,842,967 | 52.04M |
| 95 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | -1.19% | 948,084 | 298.30M |
| 96 | PHVS | Pharvaris N.V. | 2.01B | -6.80% | 480,649 | - |
| 97 | SRPT | Sarepta Therapeutics, Inc. | 1.97B | -0.85% | 3,284,753 | 2.18B |
| 98 | GENB | Generate Biomedicines, Inc. | 1.97B | -4.62% | 326,205 | 30.30M |
| 99 | ADMA | ADMA Biologics, Inc. | 1.97B | - | 3,317,734 | 509.86M |
| 100 | STOK | Stoke Therapeutics, Inc. | 1.95B | -1.07% | 533,855 | 32.08M |
| 101 | SION | Sionna Therapeutics, Inc. | 1.93B | -0.81% | 342,366 | - |
| 102 | MESO | Mesoblast Limited | 1.92B | 2.38% | 285,650 | 65.38M |
| 103 | AAPG | Ascentage Pharma Group International | 1.88B | -5.61% | 9,209 | 82.08M |
| 104 | LKFT | Lakefront Biotherapeutics NV | 1.83B | -2.31% | 130,546 | 1.20B |
| 105 | NTLA | Intellia Therapeutics, Inc. | 1.83B | -8.33% | 14,166,235 | 66.09M |
| 106 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | -1.63% | 2,322,867 | 217.17M |
| 107 | RAPP | Rapport Therapeutics, Inc. | 1.82B | -0.34% | 207,853 | 20.00M |
| 108 | TSHA | Taysha Gene Therapies, Inc. | 1.81B | -5.55% | 1,853,637 | 7.47M |
| 109 | ANAB | AnaptysBio, Inc. | 1.81B | -0.80% | 469,373 | 232.39M |
| 110 | VRDN | Viridian Therapeutics, Inc. | 1.80B | 2.29% | 2,120,587 | 70.92M |
| 111 | OCS | Oculis Holding AG | 1.79B | -3.67% | 243,127 | 1.40M |
| 112 | HRMY | Harmony Biosciences Holdings, Inc. | 1.78B | -0.23% | 518,428 | 899.11M |
| 113 | QURE | uniQure N.V. | 1.75B | -4.87% | 1,515,614 | 18.09M |
| 114 | ZYME | Zymeworks Inc. | 1.75B | -2.48% | 557,688 | 81.26M |
| 115 | CAPR | Capricor Therapeutics, Inc. | 1.73B | -1.71% | 865,100 | 11.13M |
| 116 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | -0.14% | 611,502 | 66.05M |
| 117 | PVLA | Palvella Therapeutics, Inc. | 1.71B | -1.33% | 157,108 | - |
| 118 | INBX | Inhibrx Biosciences, Inc. | 1.70B | -1.52% | 292,900 | 1.30M |
| 119 | VCEL | Vericel Corporation | 1.69B | 0.91% | 453,202 | 292.09M |
| 120 | INVA | Innoviva, Inc. | 1.69B | -1.21% | 633,943 | 420.69M |
| 121 | MBX | MBX Biosciences, Inc. | 1.68B | -5.71% | 839,976 | - |
| 122 | NRIX | Nurix Therapeutics, Inc. | 1.65B | -1.11% | 529,073 | 71.78M |
| 123 | NUVB | Nuvation Bio Inc. | 1.64B | -1.26% | 3,077,466 | 143.05M |
| 124 | PGEN | Precigen, Inc. | 1.64B | 10.84% | 9,730,900 | 31.60M |
| 125 | RXRX | Recursion Pharmaceuticals, Inc. | 1.61B | -0.33% | 15,009,906 | 66.41M |
| 126 | ARDX | Ardelyx, Inc. | 1.60B | 1.25% | 2,075,751 | 427.68M |
| 127 | GLUE | Monte Rosa Therapeutics, Inc. | 1.58B | -1.48% | 530,246 | 42.95M |
| 128 | IOVA | Iovance Biotherapeutics, Inc. | 1.57B | -3.83% | 12,614,581 | 285.61M |
| 129 | NVAX | Novavax, Inc. | 1.54B | 1.30% | 4,610,176 | 596.34M |
| 130 | VIR | Vir Biotechnology, Inc. | 1.53B | -2.57% | 1,555,673 | 65.50M |
| 131 | IMTX | Immatics N.V. | 1.50B | 3.52% | 308,864 | 43.00M |
| 132 | ATAI | AtaiBeckley Inc. | 1.48B | -4.72% | 2,885,265 | 3.49M |
| 133 | MAZE | Maze Therapeutics, Inc. | 1.46B | -1.97% | 350,980 | 20.00M |
| 134 | IMCR | Immunocore Holdings plc | 1.46B | -0.66% | 151,903 | 412.81M |
| 135 | URGN | UroGen Pharma Ltd. | 1.45B | -4.07% | 825,732 | 140.49M |
| 136 | DMRA | Damora Therapeutics, Inc. | 1.44B | -1.16% | 194,402 | - |
| 137 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | -0.15% | 3,471,693 | 73.62M |
| 138 | SLS | SELLAS Life Sciences Group, Inc. | 1.38B | 13.63% | 16,800,580 | - |
| 139 | GHRS | GH Research PLC | 1.38B | 1.51% | 166,385 | - |
| 140 | BHVN | Biohaven Ltd. | 1.36B | -0.11% | 1,642,166 | - |
| 141 | BCAX | Bicara Therapeutics Inc. | 1.36B | -1.62% | 1,294,913 | - |
| 142 | FTRE | Fortrea Holdings Inc. | 1.35B | -1.67% | 1,036,574 | 2.71B |
| 143 | ABCL | AbCellera Biologics Inc. | 1.34B | -7.76% | 7,372,192 | 79.21M |
| 144 | MLTX | MoonLake Immunotherapeutics | 1.34B | -0.11% | 692,089 | - |
| 145 | SVRA | Savara Inc. | 1.34B | - | 1,315,512 | - |
| 146 | MPLT | MapLight Therapeutics, Inc. | 1.33B | -4.27% | 275,888 | - |
| 147 | WVE | Wave Life Sciences Ltd. | 1.33B | -1.29% | 3,169,551 | 71.80M |
| 148 | AVBP | ArriVent BioPharma, Inc. | 1.32B | -1.76% | 274,758 | - |
| 149 | AVLN | Avalyn Pharma Inc. | 1.28B | -0.68% | 178,225 | - |
| 150 | SEPN | Septerna, Inc. | 1.28B | 14.42% | 556,102 | 72.26M |
| 151 | COAG | Hemab Therapeutics Holdings, Inc. | 1.25B | -0.67% | 157,626 | - |
| 152 | OLMA | Olema Pharmaceuticals, Inc. | 1.21B | 1.77% | 1,164,628 | - |
| 153 | ZBIO | Zenas BioPharma, Inc. | 1.19B | -5.17% | 510,725 | 10.00M |
| 154 | JBIO | Jade Biosciences, Inc. | 1.19B | -3.75% | 149,187 | - |
| 155 | DBVT | DBV Technologies S.A. | 1.17B | 1.28% | 174,956 | 5.74M |
| 156 | IVA | Inventiva S.A. | 1.16B | 0.18% | 137,235 | 7.94M |
| 157 | CRVS | Corvus Pharmaceuticals, Inc. | 1.15B | -13.79% | 3,946,300 | - |
| 158 | EYPT | EyePoint, Inc. | 1.11B | -1.41% | 514,832 | 7.61M |
| 159 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.11B | -1.83% | 2,046,319 | 204.73M |
| 160 | AKTS | Aktis Oncology, Inc. | 1.08B | -0.15% | 114,565 | 8.28M |
| 161 | PHAT | Phathom Pharmaceuticals, Inc. | 1.04B | 3.90% | 1,674,924 | 204.89M |
| 162 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -4.51% | 2,521,221 | 69.64M |
| 163 | MNKD | MannKind Corporation | 994.82M | 0.31% | 3,592,242 | 360.78M |
| 164 | CGEM | Cullinan Therapeutics, Inc. | 992.55M | -1.10% | 771,611 | - |
| 165 | OMER | Omeros Corporation | 961.14M | -7.65% | 3,446,003 | 9.89M |
| 166 | PHAR | Pharming Group N.V. | 929.08M | -0.08% | 12,678 | 369.49M |
| 167 | MGTX | MeiraGTx Holdings plc | 921.46M | -0.20% | 904,081 | 79.76M |
| 168 | DRTS | Alpha Tau Medical Ltd. | 916.18M | 7.99% | 1,029,230 | - |
| 169 | DSGN | Design Therapeutics, Inc. | 908.12M | -6.91% | 296,986 | - |
| 170 | LBRX | LB Pharmaceuticals Inc | 900.73M | -2.79% | 77,171 | - |
| 171 | GERN | Geron Corporation | 898.13M | -0.71% | 18,612,268 | 196.12M |
| 172 | SPTX | Seaport Therapeutics, Inc. | 895.90M | 2.39% | 380,275 | - |
| 173 | XNCR | Xencor, Inc. | 880.80M | -4.04% | 527,665 | 97.36M |
| 174 | ANNX | Annexon, Inc. | 879.83M | -1.47% | 1,588,011 | - |
| 175 | JANX | Janux Therapeutics, Inc. | 877.56M | -1.51% | 754,287 | 13.73M |
| 176 | SANA | Sana Biotechnology, Inc. | 873.84M | -1.88% | 22,775,853 | - |
| 177 | KURA | Kura Oncology, Inc. | 864.66M | 2.74% | 2,022,433 | 71.64M |
| 178 | ABSI | Absci Corporation | 863.71M | 4.53% | 5,265,974 | 1.84M |
| 179 | ORIC | ORIC Pharmaceuticals, Inc. | 863.34M | -3.02% | 2,736,285 | - |
| 180 | ABUS | Arbutus Biopharma Corporation | 859.29M | 0.93% | 926,160 | 191.45M |
| 181 | TBPH | Theravance Biopharma, Inc. | 851.14M | -0.96% | 386,644 | 109.78M |
| 182 | ANRO | Alto Neuroscience, Inc. | 826.89M | 3.24% | 509,839 | - |
| 183 | AURA | Aura Biosciences, Inc. | 825.02M | -0.50% | 335,596 | - |
| 184 | CTMX | CytomX Therapeutics, Inc. | 822.92M | -0.26% | 2,460,265 | 35.54M |
| 185 | EVMN | Evommune, Inc. | 818.34M | -2.45% | 266,042 | 10.00M |
| 186 | ODTX | Odyssey Therapeutics, Inc. | 817.06M | -3.46% | 356,655 | 2.98M |
| 187 | VOR | Vor Biopharma Inc. | 816.58M | -5.28% | 993,089 | - |
| 188 | SGP | SpyGlass Pharma, Inc. | 811.26M | 1.89% | 30,836 | - |
| 189 | SPRY | ARS Pharmaceuticals, Inc. | 788.45M | -0.87% | 2,403,504 | 84.28M |
| 190 | RLMD | Relmada Therapeutics, Inc. | 778.27M | -0.93% | 423,255 | - |
| 191 | DRUG | Bright Minds Biosciences Inc. | 763.26M | -8.21% | 365,356 | - |
| 192 | SLDB | Solid Biosciences Inc. | 751.17M | 3.39% | 1,543,712 | - |
| 193 | ALLO | Allogene Therapeutics, Inc. | 738.63M | -8.15% | 9,164,460 | 22.00K |
| 194 | EIKN | Eikon Therapeutics, Inc. | 713.55M | 7.07% | 441,067 | - |
| 195 | CBIO | Crescent Biopharma, Inc. | 705.45M | 8.26% | 171,819 | 11.88M |
| 196 | TENX | Tenax Therapeutics, Inc. | 700.65M | -0.08% | 348,383 | - |
| 197 | ZVRA | Zevra Therapeutics, Inc. | 689.28M | 4.86% | 3,090,790 | 122.29M |
| 198 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 681.08M | 5.32% | 343,230 | - |
| 199 | ACRS | Aclaris Therapeutics, Inc. | 670.39M | -5.70% | 2,215,621 | 8.37M |
| 200 | CADL | Candel Therapeutics, Inc. | 652.84M | -0.34% | 3,024,835 | - |
| 201 | KYTX | Kyverna Therapeutics, Inc. | 650.10M | -0.37% | 912,770 | - |
| 202 | GYRE | Gyre Therapeutics, Inc. | 639.60M | -3.85% | 213,266 | 117.05M |
| 203 | STRO | Sutro Biopharma, Inc. | 636.54M | -2.98% | 117,413 | 102.48M |
| 204 | TRAX | First Tracks Biotherapeutics, Inc. | 631.04M | -1.47% | 211,550 | - |
| 205 | CRMD | CorMedix Inc. | 622.05M | 5.73% | 4,321,451 | 400.05M |
| 206 | ARVN | Arvinas, Inc. | 607.79M | -4.56% | 1,059,975 | 89.40M |
| 207 | FBRX | Forte Biosciences, Inc. | 607.66M | -2.84% | 127,447 | - |
| 208 | RIGL | Rigel Pharmaceuticals, Inc. | 590.59M | -0.65% | 450,657 | 299.77M |
| 209 | CABA | Cabaletta Bio, Inc. | 588.61M | 0.56% | 3,280,920 | - |
| 210 | ALT | Altimmune, Inc. | 567.86M | -3.31% | 2,388,259 | 36.00K |
| 211 | VALN | Valneva SE | 567.81M | 1.87% | 47,722 | 180.25M |
| 212 | PRME | Prime Medicine, Inc. | 565.33M | -4.28% | 2,244,191 | 4.03M |
| 213 | TECX | Tectonic Therapeutic, Inc. | 562.30M | 3.44% | 234,914 | - |
| 214 | ANL | Adlai Nortye Ltd. | 554.40M | -0.57% | 122,175 | 5.00M |
| 215 | AGMB | AgomAb Therapeutics NV | 543.70M | -1.25% | 123,899 | - |
| 216 | CLYM | Climb Bio, Inc. | 541.22M | -0.70% | 435,755 | - |
| 217 | IMMX | Immix Biopharma, Inc. | 535.42M | -3.72% | 759,864 | - |
| 218 | CTNM | Contineum Therapeutics, Inc. | 531.26M | 0.42% | 109,261 | - |
| 219 | MDXG | MiMedx Group, Inc. | 528.76M | 0.85% | 1,106,522 | 389.42M |
| 220 | XOMA | XOMA Royalty Corporation | 526.35M | 0.41% | 162,820 | 48.56M |
| 221 | PROK | ProKidney Corp. | 516.35M | -2.29% | 1,110,453 | 893.00K |
| 222 | PRTA | Prothena Corporation plc | 516.20M | 2.71% | 452,435 | 57.94M |
| 223 | FDMT | 4D Molecular Therapeutics, Inc. | 512.83M | -6.12% | 428,753 | 88.24M |
| 224 | DNA | Ginkgo Bioworks Holdings, Inc. | 512.80M | -8.61% | 1,060,916 | 151.40M |
| 225 | AVTX | Avalo Therapeutics, Inc. | 507.84M | -4.23% | 1,706,659 | 59.00K |
| 226 | STTK | Shattuck Labs, Inc. | 504.13M | -1.19% | 413,730 | 1.00M |
| 227 | OCGN | Ocugen, Inc. | 494.23M | -0.68% | 4,238,647 | 4.47M |
| 228 | NGNE | Neurogene Inc. | 494.13M | -4.14% | 122,168 | 925.00K |
| 229 | OVID | Ovid Therapeutics Inc. | 484.50M | - | 1,324,026 | 7.12M |
| 230 | ASMB | Assembly Biosciences, Inc. | 481.55M | -4.48% | 69,452 | 71.10M |
| 231 | UPB | Upstream Bio, Inc. | 478.35M | -6.09% | 568,869 | 3.32M |
| 232 | VTVT | vTv Therapeutics Inc. | 476.90M | 21.35% | 147,575 | 36.84M |
| 233 | FULC | Fulcrum Therapeutics, Inc. | 473.76M | -1.93% | 501,071 | 80.00M |
| 234 | EPRX | Eupraxia Pharmaceuticals Inc. | 469.20M | -5.17% | 131,956 | - |
| 235 | ZURA | Zura Bio Limited | 458.27M | 0.63% | 238,800 | - |
| 236 | SGMT | Sagimet Biosciences Inc. | 455.11M | -3.03% | 684,130 | - |
| 237 | PRLD | Prelude Therapeutics Incorporated | 449.58M | -4.08% | 263,457 | 16.72M |
| 238 | LYEL | Lyell Immunopharma, Inc. | 443.78M | -1.14% | 37,593 | 31.00K |
| 239 | PRTC | PureTech Health plc | 442.35M | 2.57% | 4,275 | 4.66M |
| 240 | LXEO | Lexeo Therapeutics, Inc. | 431.87M | -4.51% | 424,429 | - |
| 241 | IPSC | Century Therapeutics, Inc. | 429.24M | 4.39% | 756,909 | 109.16M |
| 242 | ADCT | ADC Therapeutics SA | 427.36M | -3.45% | 903,984 | 79.18M |
| 243 | AUTL | Autolus Therapeutics plc | 423.17M | -7.02% | 2,996,641 | 75.39M |
| 244 | VSTM | Verastem, Inc. | 413.88M | -0.21% | 1,740,114 | 49.59M |
| 245 | MNPR | Monopar Therapeutics Inc. | 408.56M | -0.73% | 483,812 | - |
| 246 | BNTC | Benitec Biopharma Inc. | 407.10M | 1.72% | 64,011 | - |
| 247 | REPL | Replimune Group, Inc. | 407.08M | -6.98% | 9,285,221 | - |
| 248 | LRMR | Larimar Therapeutics, Inc. | 404.10M | -5.12% | 3,647,385 | - |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 400.76M | -1.57% | 269,710 | 69.21M |
| 250 | CCCC | C4 Therapeutics, Inc. | 399.96M | -1.36% | 2,822,721 | 34.86M |
| 251 | VNDA | Vanda Pharmaceuticals Inc. | 384.27M | -0.62% | 738,329 | 217.78M |
| 252 | XFOR | X4 Pharmaceuticals, Inc. | 377.28M | -5.44% | 264,582 | 9.01M |
| 253 | RCKT | Rocket Pharmaceuticals, Inc. | 371.26M | -5.56% | 2,051,209 | - |
| 254 | PBYI | Puma Biotechnology, Inc. | 365.97M | 0.28% | 251,402 | 227.18M |
| 255 | NMRA | Neumora Therapeutics, Inc. | 359.90M | 10.67% | 1,375,784 | - |
| 256 | GLSI | Greenwich LifeSciences, Inc. | 359.80M | 2.65% | 151,528 | - |
| 257 | CMPX | Compass Therapeutics, Inc. | 356.57M | 0.51% | 5,574,862 | 850.00K |
| 258 | YDES | YD Bio Limited | 355.82M | -2.69% | 5,150 | 510.36K |
| 259 | RZLT | Rezolute, Inc. | 355.19M | 2.10% | 1,072,891 | - |
| 260 | IRD | Opus Genetics, Inc. | 354.87M | -1.19% | 905,666 | 11.98M |
| 261 | IFRX | InflaRx N.V. | 350.56M | -5.56% | 2,350,537 | 33.82K |
| 262 | SRZN | Surrozen, Inc. | 343.11M | -0.90% | 14,861 | 7.49M |
| 263 | DMAC | DiaMedica Therapeutics Inc. | 342.97M | 1.68% | 94,978 | - |
| 264 | AVIR | Atea Pharmaceuticals, Inc. | 341.72M | -6.56% | 685,257 | - |
| 265 | SLN | Silence Therapeutics plc | 336.78M | 2.15% | 63,769 | 839.00K |
| 266 | NAUT | Nautilus Biotechnology, Inc. | 332.95M | -11.19% | 644,770 | - |
| 267 | IMRX | Immuneering Corporation | 332.54M | -4.46% | 880,694 | - |
| 268 | NVCT | Nuvectis Pharma, Inc. | 330.24M | 3.41% | 170,360 | - |
| 269 | IVVD | Invivyd, Inc. | 328.05M | -21.09% | 11,553,421 | 53.43M |
| 270 | LCTX | Lineage Cell Therapeutics, Inc. | 326.58M | 2.34% | 2,039,271 | 14.78M |
| 271 | BCYC | Bicycle Therapeutics plc | 325.53M | -1.48% | 252,278 | 63.50M |
| 272 | RGNX | REGENXBIO Inc. | 322.35M | -37.80% | 10,322,862 | 87.82M |
| 273 | FENC | Fennec Pharmaceuticals Inc. | 320.75M | 36.48% | 2,268,605 | 51.00M |
| 274 | ABEO | Abeona Therapeutics Inc. | 319.17M | -1.93% | 1,623,526 | 14.54M |
| 275 | OABI | OmniAb, Inc. | 317.49M | 8.96% | 1,137,200 | 28.94M |
| 276 | IKT | Inhibikase Therapeutics, Inc. | 316.99M | -2.11% | 287,391 | 1.00 |
| 277 | ACHV | Achieve Life Sciences, Inc. | 308.26M | -2.85% | 906,227 | - |
| 278 | ELDN | Eledon Pharmaceuticals, Inc. | 305.34M | 1.80% | 2,040,240 | - |
| 279 | NAGE | Niagen Bioscience, Inc. | 303.28M | 1.06% | 815,781 | 130.42M |
| 280 | PALI | Palisade Bio, Inc. | 303.04M | -3.21% | 1,216,233 | - |
| 281 | CLLS | Cellectis S.A. | 302.50M | 2.26% | 23,583 | 75.11M |
| 282 | ARMP | Armata Pharmaceuticals, Inc. | 300.90M | -7.03% | 75,725 | 5.20M |
| 283 | NGEN | NervGen Pharma Corp. | 300.25M | 1.92% | 123,038 | - |
| 284 | TARA | Protara Therapeutics, Inc. | 297.88M | 1.92% | 543,043 | - |
| 285 | ZNTL | Zentalis Pharmaceuticals, Inc. | 291.15M | -4.44% | 2,593,579 | 26.87M |
| 286 | CGEN | Compugen Ltd. | 286.50M | 6.32% | 772,840 | 72.76M |
| 287 | AVXL | Anavex Life Sciences Corp. | 285.43M | - | 1,250,747 | - |
| 288 | EDIT | Editas Medicine, Inc. | 279.03M | -1.72% | 1,136,622 | 38.69M |
| 289 | ACIU | AC Immune SA | 277.76M | -1.41% | 368,912 | 4.62M |
| 290 | ALXO | ALX Oncology Holdings Inc. | 274.50M | 0.49% | 406,012 | - |
| 291 | SABS | SAB Biotherapeutics, Inc. | 273.37M | -1.77% | 712,894 | 114.70K |
| 292 | MGNX | MacroGenics, Inc. | 264.41M | 20.58% | 3,657,273 | 157.08M |
| 293 | ARTV | Artiva Biotherapeutics, Inc. | 263.97M | 1.71% | 389,628 | 251.00K |
| 294 | VYGR | Voyager Therapeutics, Inc. | 256.19M | 2.17% | 814,208 | 36.49M |
| 295 | ALEC | Alector, Inc. | 255.36M | 6.98% | 783,208 | 18.42M |
| 296 | HELP | Cybin Inc. | 253.18M | -2.32% | 453,230 | - |
| 297 | WHWK | Whitehawk Therapeutics, Inc. | 252.08M | 3.45% | 391,179 | 7.15M |
| 298 | CHRS | Coherus Oncology, Inc. | 251.43M | -4.40% | 1,982,416 | 46.88M |
| 299 | OBIO | Orchestra BioMed Holdings, Inc. | 246.11M | 1.23% | 627,258 | 32.72M |
| 300 | TRDA | Entrada Therapeutics, Inc. | 246.11M | -6.69% | 779,040 | 5.74M |
| 301 | RNAC | Cartesian Therapeutics, Inc. | 242.99M | -1.78% | 82,322 | 1.78M |
| 302 | ADAG | Adagene Inc. | 241.83M | -1.08% | 2,086 | 7.67M |
| 303 | NERV | Minerva Neurosciences, Inc. | 241.13M | -0.90% | 63,005 | - |
| 304 | FHTX | Foghorn Therapeutics Inc. | 237.20M | -3.12% | 110,448 | 28.22M |
| 305 | CDXS | Codexis, Inc. | 233.60M | 2.80% | 794,933 | 78.09M |
| 306 | LENZ | LENZ Therapeutics, Inc. | 228.57M | -9.44% | 998,693 | 20.99M |
| 307 | UNCY | Unicycive Therapeutics, Inc. | 228.55M | 0.59% | 479,369 | - |
| 308 | CAMP | Camp4 Therapeutics Corporation | 227.44M | -2.67% | 37,158 | 3.93M |
| 309 | TNXP | Tonix Pharmaceuticals Holding Corp. | 224.61M | 1.81% | 467,251 | 17.56M |
| 310 | SLGL | Sol-Gel Technologies Ltd. | 224.51M | -5.98% | 7,990 | 19.39M |
| 311 | ARCT | Arcturus Therapeutics Holdings Inc. | 222.55M | -5.21% | 522,388 | 54.71M |
| 312 | NBP | NovaBridge Biosciences | 222.05M | -6.34% | 712,427 | - |
| 313 | HUMA | Humacyte, Inc. | 222.02M | -11.50% | 10,112,809 | 2.02M |
| 314 | MIST | Milestone Pharmaceuticals Inc. | 221.76M | -5.23% | 3,880,412 | 1.78M |
| 315 | FATE | Fate Therapeutics, Inc. | 221.46M | -11.01% | 3,763,441 | 6.32M |
| 316 | KROS | Keros Therapeutics, Inc. | 217.47M | -8.34% | 725,378 | 33.18M |
| 317 | MDWD | MediWound Ltd. | 215.85M | 3.35% | 64,050 | 16.96M |
| 318 | CNTX | Context Therapeutics Inc. | 214.08M | -1.27% | 416,522 | - |
| 319 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 212.48M | -1.40% | 218,058 | - |
| 320 | CNTN | Canton Strategic Holdings, Inc. | 212.46M | 6.84% | 851,786 | - |
| 321 | CRBU | Caribou Biosciences, Inc. | 210.27M | 0.94% | 3,446,874 | 11.20M |
| 322 | DTIL | Precision BioSciences, Inc. | 209.26M | -2.76% | 236,847 | 45.07M |
| 323 | RNA | Atrium Therapeutics, Inc. | 205.88M | -0.23% | 100,216 | 18.62M |
| 324 | TNYA | Tenaya Therapeutics, Inc. | 202.89M | -2.55% | 5,631,896 | 225.00K |
| 325 | NKTX | Nkarta, Inc. | 201.04M | -8.17% | 837,954 | - |
| 326 | KPTI | Karyopharm Therapeutics Inc. | 200.64M | 0.56% | 1,008,979 | 146.07M |
| 327 | ELTX | Elicio Therapeutics, Inc. | 200.52M | -3.54% | 77,778 | - |
| 328 | ORMP | Oramed Pharmaceuticals Inc. | 191.31M | 3.73% | 117,948 | 2.00M |
| 329 | TLSA | Tiziana Life Sciences Ltd | 185.05M | -3.33% | 279,677 | - |
| 330 | ENLV | Enlivex Ltd. | 176.50M | -0.03% | 209,858 | - |
| 331 | PRQR | ProQR Therapeutics N.V. | 173.85M | -2.94% | 360,257 | 15.73M |
| 332 | HRTX | Heron Therapeutics, Inc. | 172.70M | -0.22% | 1,810,221 | 150.71M |
| 333 | ABOS | Acumen Pharmaceuticals, Inc. | 172.62M | -4.02% | 262,835 | - |
| 334 | IMUX | Immunic, Inc. | 172.38M | -2.28% | 213,502 | - |
| 335 | ANTX | AN2 Therapeutics, Inc. | 167.02M | 7.66% | 295,944 | - |
| 336 | BDTX | Black Diamond Therapeutics, Inc. | 163.88M | - | 578,124 | 70.00M |
| 337 | EQ | Equillium, Inc. | 163.76M | 12.12% | 542,157 | 4.39M |
| 338 | PLYX | Polaryx Therapeutics, Inc. | 161.44M | 1.34% | 174,259 | - |
| 339 | PLX | Protalix BioTherapeutics, Inc. | 161.14M | 3.63% | 869,761 | 76.38M |
| 340 | MENS | Jyong Biotech Ltd. | 159.95M | 2.97% | 42,757 | - |
| 341 | SPRO | Spero Therapeutics, Inc. | 159.81M | 13.11% | 1,606,705 | 61.19M |
| 342 | KRRO | Korro Bio, Inc. | 159.80M | -1.07% | 63,065 | 3.84M |
| 343 | HURA | TuHURA Biosciences, Inc. | 159.58M | - | 347,054 | - |
| 344 | SPRB | Spruce Biosciences, Inc. | 159.43M | 2.52% | 29,239 | 697.00K |
| 345 | KZIA | Kazia Therapeutics Limited | 158.03M | -1.21% | 143,490 | 1.27M |
| 346 | GALT | Galectin Therapeutics Inc. | 154.69M | 5.38% | 239,261 | - |
| 347 | GUTS | Fractyl Health, Inc. | 151.35M | 0.60% | 5,100,687 | 3.00K |
| 348 | AGEN | Agenus Inc. | 148.71M | 3.17% | 434,481 | 123.87M |
| 349 | AARD | Aardvark Therapeutics, Inc. | 146.82M | 2.12% | 166,805 | - |
| 350 | MOLN | Molecular Partners AG | 143.91M | -4.00% | 3,097 | 856.30K |
| 351 | ALPS | Alps Group Inc | 143.10M | 2.37% | 14,577 | 3.74M |
| 352 | CNTB | Connect Biopharma Holdings Limited | 140.17M | 1.22% | 160,226 | 233.00K |
| 353 | PYXS | Pyxis Oncology, Inc. | 138.91M | -15.65% | 1,063,203 | 13.86M |
| 354 | NTHI | NeOnc Technologies Holdings, Inc. | 137.53M | 0.74% | 78,566 | 39.99K |
| 355 | GNLX | Genelux Corporation | 135.00M | -4.70% | 289,295 | 8.00K |
| 356 | OKUR | OnKure Therapeutics, Inc. | 134.92M | -1.76% | 90,199 | - |
| 357 | IPHA | Innate Pharma S.A. | 134.92M | 64.39% | 2,385,219 | 10.57M |
| 358 | EDSA | Edesa Biotech, Inc. | 129.82M | -4.13% | 132,206 | - |
| 359 | ACOG | Alpha Cognition Inc. | 123.68M | -4.54% | 37,520 | 10.22M |
| 360 | COYA | Coya Therapeutics, Inc. | 123.38M | 15.86% | 440,715 | 7.94M |
| 361 | ENGN | enGene Therapeutics Inc. | 121.25M | 17.53% | 6,941,912 | - |
| 362 | KLRS | Kalaris Therapeutics, Inc. | 120.02M | 8.07% | 171,581 | - |
| 363 | TTRX | Turn Therapeutics Inc. | 119.75M | 0.25% | 20,333 | - |
| 364 | VRCA | Verrica Pharmaceuticals Inc. | 119.39M | -5.70% | 82,234 | 37.16M |
| 365 | CRDF | Cardiff Oncology, Inc. | 118.28M | 2.37% | 538,997 | 593.00K |
| 366 | PEPG | PepGen Inc. | 114.13M | -7.30% | 1,081,235 | - |
| 367 | INO | Inovio Pharmaceuticals, Inc. | 111.44M | 1.49% | 2,512,640 | 65.34K |
| 368 | RANI | Rani Therapeutics Holdings, Inc. | 110.79M | 5.71% | 1,586,738 | 1.63M |
| 369 | CBUS | Cibus, Inc. | 107.56M | -3.09% | 224,245 | 3.64M |
| 370 | CGTX | Cognition Therapeutics, Inc. | 107.22M | - | 850,903 | - |
| 371 | NRXP | NRx Pharmaceuticals, Inc. | 106.04M | 8.81% | 1,511,690 | 1.23M |
| 372 | QTTB | Q32 Bio Inc. | 105.98M | 5.22% | 157,530 | 53.74M |
| 373 | VANI | Vivani Medical, Inc. | 103.48M | 3.45% | 288,709 | - |
| 374 | BMEA | Biomea Fusion, Inc. | 103.39M | -3.38% | 1,243,459 | - |
| 375 | LONA | LeonaBio, Inc. | 103.33M | 6.59% | 85,519 | - |
| 376 | ONCY | Oncolytics Biotech Inc. | 101.37M | 0.22% | 754,750 | - |
| 377 | ALDX | Aldeyra Therapeutics, Inc. | 100.13M | -2.35% | 709,781 | - |
| 378 | SEER | Seer, Inc. | 98.74M | -1.13% | 517,854 | 15.17M |
| 379 | ANIX | Anixa Biosciences, Inc. | 96.90M | -0.34% | 101,135 | - |
| 380 | NRXS | NeurAxis, Inc. | 96.07M | 5.56% | 202,738 | 4.28M |
| 381 | PMN | ProMIS Neurosciences, Inc. | 94.88M | 0.09% | 18,462 | - |
| 382 | PTHS | Pelthos Therapeutics Inc. | 92.91M | 6.46% | 47,421 | 16.80M |
| 383 | ACET | Adicet Bio, Inc. | 88.31M | 4.21% | 155,435 | - |
| 384 | RNTX | Rein Therapeutics Inc. | 88.18M | -2.59% | 341,668 | - |
| 385 | CSBR | Champions Oncology, Inc. | 86.24M | 3.16% | 14,387 | 57.95M |
| 386 | EXOZ | eXoZymes, Inc. | 84.96M | 1.42% | 3,456 | -700.00 |
| 387 | OKYO | OKYO Pharma Limited | 84.49M | -0.62% | 35,159 | - |
| 388 | PYPD | PolyPid Ltd. | 83.30M | 3.44% | 94,510 | - |
| 389 | ATHE | Alterity Therapeutics Limited | 82.93M | 1.08% | 27,823 | 4.43M |
| 390 | MAIA | MAIA Biotechnology, Inc. | 82.51M | 5.43% | 553,288 | - |
| 391 | CUE | Cue Biopharma, Inc. | 82.46M | -14.05% | 168,423 | 27.47M |
| 392 | ACRV | Acrivon Therapeutics, Inc. | 82.18M | - | 599,455 | - |
| 393 | ATRA | Atara Biotherapeutics, Inc. | 81.63M | -8.49% | 302,518 | 23.14M |
| 394 | PDSB | PDS Biotechnology Corporation | 79.82M | 7.52% | 2,255,019 | - |
| 395 | OSTX | OS Therapies Incorporated | 79.03M | 5.03% | 1,820,928 | - |
| 396 | GANX | Gain Therapeutics, Inc. | 77.63M | 2.25% | 447,107 | - |
| 397 | GOSS | Gossamer Bio, Inc. | 77.45M | -3.96% | 2,707,312 | 48.47M |
| 398 | MCRB | Seres Therapeutics, Inc. | 77.35M | 3.48% | 36,594 | 1.15M |
| 399 | FBIO | Fortress Biotech, Inc. | 76.40M | 3.14% | 529,743 | 63.26M |
| 400 | XBIT | XBiotech Inc. | 76.22M | - | 6,184 | - |
| 401 | RLYB | Rallybio Corporation | 75.17M | -0.98% | 41,710 | 858.00K |
| 402 | ICCC | ImmuCell Corporation | 74.73M | -1.20% | 25,190 | 27.64M |
| 403 | ANVS | Annovis Bio, Inc. | 73.80M | -4.05% | 732,137 | - |
| 404 | PLRX | Pliant Therapeutics, Inc. | 72.13M | -0.43% | 197,967 | - |
| 405 | PMVP | PMV Pharmaceuticals, Inc. | 70.93M | 3.10% | 553,757 | - |
| 406 | MNOV | MediciNova, Inc. | 68.91M | 2.19% | 22,270 | 409.66K |
| 407 | ACTU | Actuate Therapeutics, Inc. | 68.76M | -2.36% | 35,656 | - |
| 408 | TCRX | TScan Therapeutics, Inc. | 66.71M | -4.31% | 878,314 | 9.14M |
| 409 | DWTX | Dogwood Therapeutics, Inc. | 66.14M | 6.45% | 83,549 | - |
| 410 | IMA | ImageneBio, Inc. | 66.10M | 2.43% | 11,753 | 800.00K |
| 411 | ENTX | Entera Bio Ltd. | 65.47M | 3.10% | 100,375 | 42.00K |
| 412 | HYFT | MindWalk Holdings Corp. | 62.58M | - | 80,387 | 20.70M |
| 413 | BYSI | BeyondSpring Inc. | 60.45M | 1.38% | 9,173 | 1.88M |
| 414 | IMMP | Immutep Limited | 59.94M | -2.69% | 569,848 | 5.28M |
| 415 | FLNA | Filana Therapeutics, Inc. | 59.90M | 0.81% | 376,202 | - |
| 416 | IBO | Impact BioMedical Inc. | 59.30M | -5.47% | 73,712 | 39.00K |
| 417 | LIXT | Lixte Biotechnology Holdings, Inc. | 58.55M | 0.80% | 89,506 | - |
| 418 | KALA | KALA BIO, Inc. | 57.44M | 0.98% | 30,702 | - |
| 419 | IBIO | iBio, Inc. | 56.38M | 0.65% | 706,615 | 300.00K |
| 420 | ATYR | aTyr Pharma, Inc. | 54.90M | 41.42% | 13,901,993 | 190.00K |
| 421 | TIL | Instil Bio, Inc. | 54.56M | 0.31% | 20,799 | - |
| 422 | CING | Cingulate Inc. | 53.78M | -10.77% | 989,036 | - |
| 423 | XLO | Xilio Therapeutics, Inc. | 52.71M | 13.53% | 724,605 | 53.48M |
| 424 | INKT | MiNK Therapeutics, Inc. | 52.36M | -4.89% | 65,365 | - |
| 425 | HYPD | Hyperion DeFi, Inc. | 51.43M | 3.43% | 784,299 | 813.46K |
| 426 | ESLA | Estrella Immunopharma, Inc. | 51.41M | 0.42% | 40,661 | - |
| 427 | MGX | Metagenomi Therapeutics, Inc. | 50.82M | -2.17% | 369,206 | 22.33M |
| 428 | RADX | Radiopharm Theranostics Limited | 48.91M | 4.42% | 46,841 | 10.86M |
| 429 | INMB | INmune Bio Inc. | 44.66M | 15.07% | 4,276,157 | 50.00K |
| 430 | LITS | Lite Strategy, Inc. | 44.36M | 3.39% | 301,041 | - |
| 431 | ATOS | Atossa Therapeutics, Inc. | 44.35M | -0.19% | 29,915 | - |
| 432 | TELO | Telomir Pharmaceuticals, Inc. | 43.66M | 3.25% | 75,697 | - |
| 433 | NTRB | Nutriband Inc. | 43.64M | 2.57% | 5,470 | 2.04M |
| 434 | DARE | Daré Bioscience, Inc. | 41.64M | 0.70% | 1,474,162 | 1.03M |
| 435 | ALGS | Aligos Therapeutics, Inc. | 41.40M | 0.30% | 214,103 | 4.71M |
| 436 | QNTM | Quantum BioPharma Ltd. | 40.32M | 25.59% | 827,817 | - |
| 437 | ATNM | Actinium Pharmaceuticals, Inc. | 39.91M | -0.78% | 71,805 | 90.00K |
| 438 | PSTV | Plus Therapeutics, Inc. | 39.53M | 1.05% | 161,094 | 5.21M |
| 439 | MREO | Mereo BioPharma Group plc | 39.27M | -5.20% | 1,415,500 | 500.00K |
| 440 | TVGN | Tevogen Bio Holdings Inc. | 39.23M | 39.14% | 177,577 | - |
| 441 | RNXT | RenovoRx, Inc. | 38.52M | 0.75% | 173,030 | 1.12M |
| 442 | NNVC | NanoViricides, Inc. | 37.58M | 1.16% | 514,586 | - |
| 443 | TVRD | Tvardi Therapeutics, Inc. | 37.15M | 0.25% | 16,246 | - |
| 444 | NXTC | NextCure, Inc. | 36.98M | 4.59% | 27,764 | - |
| 445 | LTRN | Lantern Pharma Inc. | 35.08M | 24.70% | 1,261,204 | - |
| 446 | CRVO | CervoMed Inc. | 34.81M | 1.08% | 19,132 | 4.01M |
| 447 | BOLD | Boundless Bio, Inc. | 34.75M | 0.65% | 282,890 | - |
| 448 | EVAX | Evaxion A/S | 34.36M | -0.96% | 55,572 | 7.53M |
| 449 | PLUR | Pluri Inc. | 34.17M | -3.13% | 10,665 | 1.34M |
| 450 | GRCE | Grace Therapeutics, Inc. | 33.89M | -2.67% | 408,621 | - |
| 451 | VERU | Veru Inc. | 33.55M | -7.52% | 192,805 | 16.89M |
| 452 | SNTI | Senti Biosciences Holdings, Inc. | 32.39M | 8.00% | 572,525 | 22.00K |
| 453 | PTN | Palatin Technologies, Inc. | 32.25M | -9.82% | 38,783 | 12.88M |
| 454 | SKYE | Skye Bioscience, Inc. | 30.60M | 6.28% | 242,266 | - |
| 455 | BCTX | BriaCell Therapeutics Corp. | 30.28M | -3.11% | 285,197 | - |
| 456 | NRSN | NeuroSense Therapeutics Ltd. | 30.08M | 2.21% | 93,470 | - |
| 457 | TPST | Tempest Therapeutics, Inc. | 29.98M | 13.59% | 255,090 | - |
| 458 | APLM | Apollomics, Inc. | 29.87M | 0.52% | 12,028 | 8.84M |
| 459 | IGC | IGC Pharma, Inc. | 29.54M | 1.01% | 161,020 | 1.11M |
| 460 | BRNS | Barinthus Biotherapeutics plc | 29.04M | 4.54% | 34,382 | 14.97M |
| 461 | KYNB | Kyntra Bio, Inc. | 28.38M | 0.14% | 9,187 | 7.44M |
| 462 | PLRZ | Polyrizon Ltd. | 28.12M | -1.05% | 68,579 | - |
| 463 | LSTA | Lisata Therapeutics, Inc. | 27.82M | -6.10% | 42,211 | 170.00K |
| 464 | NEUP | Neuphoria Therapeutics Inc. | 27.44M | 2.21% | 21,342 | 14.99M |
| 465 | JSPR | Jasper Therapeutics, Inc. | 26.85M | 4.23% | 180,414 | - |
| 466 | ABVC | ABVC BioPharma, Inc. | 26.69M | 0.93% | 76,386 | 797.92K |
| 467 | SNSE | Sensei Biotherapeutics, Inc. | 26.57M | -5.98% | 15,690 | - |
| 468 | HOWL | Werewolf Therapeutics, Inc. | 26.37M | -7.07% | 706,066 | 1.14M |
| 469 | VTGN | Vistagen Therapeutics, Inc. | 25.78M | -0.78% | 560,157 | 789.00K |
| 470 | SER | Serina Therapeutics, Inc. | 25.63M | 10.26% | 171,114 | 130.00K |
| 471 | DYAI | Dyadic International, Inc. | 25.14M | -2.89% | 74,112 | 3.09M |
| 472 | OTLK | Outlook Therapeutics, Inc. | 24.40M | 1.39% | 3,022,571 | 205.70K |
| 473 | MRKR | Marker Therapeutics, Inc. | 24.34M | 2.10% | 51,708 | 3.55M |
| 474 | CELU | Celularity Inc. | 23.40M | 3.15% | 158,834 | 26.55M |
| 475 | ALLR | Allarity Therapeutics, Inc. | 23.35M | -1.95% | 178,393 | 320.00K |
| 476 | GRDX | GridAI Technologies Corp. | 22.57M | 5.51% | 289,095 | - |
| 477 | VYNE | VYNE Therapeutics Inc. | 22.34M | 0.06% | 110,652 | 570.00K |
| 478 | AEON | AEON Biopharma, Inc. | 21.07M | -2.32% | 32,149 | - |
| 479 | LGVN | Longeveron Inc. | 20.57M | -6.94% | 861,953 | 1.22M |
| 480 | CRIS | Curis, Inc. | 20.52M | 2.66% | 117,716 | 7.06M |
| 481 | XCUR | Exicure, Inc. | 20.08M | 0.32% | 4,773 | 500.00K |
| 482 | OSRH | OSR Holdings, Inc. | 19.88M | -2.68% | 1,162,443 | 2.63M |
| 483 | KTTA | Pasithea Therapeutics Corp. | 19.81M | 1.17% | 424,748 | - |
| 484 | CTXR | Citius Pharmaceuticals, Inc. | 19.52M | 10.77% | 1,570,576 | 3.94M |
| 485 | QNCX | Quince Therapeutics, Inc. | 19.23M | -3.28% | 473,812 | - |
| 486 | LPCN | Lipocine Inc. | 18.70M | 0.43% | 130,753 | 2.00M |
| 487 | NCEL | NewcelX Ltd. | 18.47M | 5.87% | 9,280 | - |
| 488 | PASG | Passage Bio, Inc. | 17.37M | -1.90% | 41,331 | - |
| 489 | COCP | Cocrystal Pharma, Inc. | 17.37M | -1.56% | 66,838 | - |
| 490 | ICU | SeaStar Medical Holding Corporation | 16.79M | -8.70% | 163,976 | 1.44M |
| 491 | TRAW | Traws Pharma, Inc. | 16.56M | -5.23% | 913,409 | 2.79M |
| 492 | CVKD | Cadrenal Therapeutics, Inc. | 16.22M | -0.75% | 49,340 | - |
| 493 | INAB | IN8bio, Inc. | 15.66M | - | 23,350 | - |
| 494 | LEXX | Lexaria Bioscience Corp. | 15.14M | 1.41% | 120,780 | 368.00K |
| 495 | GNTA | Genenta Science S.p.A. | 14.86M | 7.36% | 79,863 | - |
| 496 | TOVX | Theriva Biologics, Inc. | 14.73M | -2.73% | 1,926,462 | 300.00K |
| 497 | GTBP | GT Biopharma, Inc. | 13.85M | 40.36% | 14,758,474 | - |
| 498 | CLRB | Cellectar Biosciences, Inc. | 13.57M | 8.84% | 412,633 | - |
| 499 | HIND | Vyome Holdings, Inc. | 13.48M | - | 43,024 | 152.72K |
| 500 | BLRX | BioLineRx Ltd. | 13.46M | -2.24% | 12,702 | 1.18M |